002644.SZ
Lanzhou Foci Pharmaceutical Co., Ltd.
SZSE · Healthcare · C 制造业 · CN
CNY 8.18
−0.24%Year over year
Reported trailing growth
- Revenue
- -1.2%
- EBITDA
- —
- EBIT
- -0.2%
- EPS
- -14.0%
- Free cash flow
- +397.2%
- Operating cash flow
- +267.0%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- -4.2%
- EBITDA
- -14.2%
- EBIT
- -22.8%
- Net income
- -23.2%
- EPS
- -23.2%
- Free cash flow
- +54.2%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026